SCHEMBL6446840

SCHEMBL6446840

COc1ccc2cc(C(C)Cl)ccc2c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.61
AKR1C3 P42330 6/20 0.59
AKR1C2 P52895 6/20 0.59
PTGS2 P35354 3/20 0.59
PTGS1 P23219 3/20 0.59
TSHR P16473 2/20 0.59
CYP1A2 P05177 2/20 0.59
CDC42 P60953 1/20 0.59
RAC1 P63000 1/20 0.59
SLC22A6 Q4U2R8 1/20 0.59
LMNA P02545 1/20 0.56
MAPT P10636 1/20 0.56
CYP2C9 P11712 1/20 0.56
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
CYP2A6 P11509 1/20 0.52
ALOX5 P09917 2/20 0.51
AKR1C1 Q04828 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38666256 1.00 ABCB11 (0.61) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL26462966 1.00 ABCB11 (0.61) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL23255698 1.00 ABCB11 (0.61) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL30640494 0.83 ABCB11 (0.65) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL487168 0.83 ABCB11 (0.65) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL29365195 0.83 ABCB11 (0.65) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL20398797 0.83 ABCB11 (0.65) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL3831944 0.82 ABCB11 (0.54) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL15701616 0.82 ABCB11 (0.62) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL365643 0.81 TDP1 (0.56) TSHRCYP1A2MAPTTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6555704-B1 Preparation of alpha-aryl-propionic acids such as ibuprofen by carbonylating the corresponding 1-arylethyl halide in an acidic aqueous medium containing a phosphine/palladium catalyst; catalyst selectivity; efficiency BASF CORPORATION 2003-04-29 US claimed
US-6268526-B1 MIXTURE FORMED FROM AN AROMATIC SUBSTITUTED ALCOHOL AND/OR AN AROMATIC SUBSTITUTED ALKYL HALIDE, AND A COPPER-FREE PALLADIUM CATALYST IS CARBONYLATED WITH CARBON MONOXIDE TO PRODUCE ALPHA-SUBSTITUTED CARBOXYLIC ACID OR ESTER ALBEMARLE CORPORATION 2001-07-31 US claimed
EP-0338852-B1 Process for the carbonylation of arylalkyl halides HOECHST CELANESE CORP (US) 1994-11-30 EP claimed
EP-0338852-A1 Process for the carbonylation of arylalkyl halides HOECHST CELANESE CORPORATION (US) 1989-10-25 EP claimed
US-4536595-A Process for the preparation of alpha-aryl-propionic acids and alkaline salts thereof MONTEDISON S.P.A. (IT) 1985-08-20 US claimed
EP-0076722-B1 PROCESS FOR THE PREPARATION OF ALPHA-ARYL-PROPIONIC ACIDS AND THEIR ALKALINE SALTS Montedison S.p.A. (IT) 1985-02-20 EP claimed
EP-0076721-B1 PROCESS FOR THE CARBONYLATION OF SECONDARY BENZYL HALIDES Montedison S.p.A. (IT) 1985-02-06 EP claimed
EP-0076722-A1 Process for the preparation of alpha-aryl-propionic acids and their alkaline salts Montedison S.p.A. (IT) 1983-04-13 EP claimed
EP-0076721-A1 Process for the carbonylation of secondary benzyl halides Montedison S.p.A. (IT) 1983-04-13 EP claimed
US-11639326-B2 Continuous flow synthesis of ibuprofen SRI INTERNATIONAL (US) 2023-05-02 US disclosed
US-11639326-B2 Continuous flow synthesis of ibuprofen SRI INTERNATIONAL (US) 2023-05-02 US disclosed
US-20210114962-A1 CONTINUOUS FLOW SYNTHESIS OF IBUPROFEN SRI INTERNATIONAL 2021-04-22 US disclosed
US-20050283020-A1 Process for the preparation of 2-aryl propionic acids CHAUDHARI RAGHUNATH V 2005-12-22 US disclosed
US-6660883-B1 Conversion of aryl alkyl compound such as aryl alkyl alcohols and aryl alkyl halides COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-12-09 US disclosed
EP-0338852-A1 Process for the carbonylation of arylalkyl halides HOECHST CELANESE CORPORATION (US) 1989-10-25 EP disclosed
US-4536595-A Process for the preparation of alpha-aryl-propionic acids and alkaline salts thereof MONTEDISON S.P.A. (IT) 1985-08-20 US disclosed
EP-0076722-B1 PROCESS FOR THE PREPARATION OF ALPHA-ARYL-PROPIONIC ACIDS AND THEIR ALKALINE SALTS Montedison S.p.A. (IT) 1985-02-20 EP disclosed
EP-0076721-B1 PROCESS FOR THE CARBONYLATION OF SECONDARY BENZYL HALIDES Montedison S.p.A. (IT) 1985-02-06 EP disclosed
EP-0076721-A1 Process for the carbonylation of secondary benzyl halides Montedison S.p.A. (IT) 1983-04-13 EP disclosed
EP-0076722-A1 Process for the preparation of alpha-aryl-propionic acids and their alkaline salts Montedison S.p.A. (IT) 1983-04-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050283020-A1 Process for the preparation of 2-aryl propionic acids ADH1C, ADH5, ADH1A ABCB11 2023/4885AKR1C3 20/4885AKR1C2 132/4885
US-20210114962-A1 CONTINUOUS FLOW SYNTHESIS OF IBUPROFEN PTGES2, PTGS2, PTGES ABCB11 276/4885AKR1C3 284/4885AKR1C2 616/4885
US-11639326-B2 Continuous flow synthesis of ibuprofen PTGES2, PTGS2, PTGES ABCB11 276/4885AKR1C3 284/4885AKR1C2 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.